ThermoGenesis Holdings, Inc. – NASDAQ:THMO

ThermoGenesis Holdings stock price today

$0
-0.00
-83.33%
Financial Health
0
1
2
3
4
5
6
7
8
9

ThermoGenesis Holdings stock price monthly change

-99.34%
month

ThermoGenesis Holdings stock price quarterly change

-99.34%
quarter

ThermoGenesis Holdings stock price yearly change

-99.83%
year

ThermoGenesis Holdings key metrics

Market Cap
2.37M
Enterprise value
716.28K
P/E
-0.11
EV/Sales
0.06
EV/EBITDA
-0.14
Price/Sales
0.12
Price/Book
0.29
PEG ratio
-0.11
EPS
-4.75
Revenue
9.61M
EBITDA
-4.82M
Income
-14.74M
Revenue Q/Q
6.41%
Revenue Y/Y
-7.52%
Profit margin
-107.51%
Oper. margin
-59.08%
Gross margin
25.85%
EBIT margin
-59.08%
EBITDA margin
-50.24%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

ThermoGenesis Holdings stock price history

ThermoGenesis Holdings stock forecast

ThermoGenesis Holdings financial statements

ThermoGenesis Holdings, Inc. (NASDAQ:THMO): Profit margin
Jun 2023 2.27M -2.26M -99.43%
Sep 2023 2.19M -3.61M -164.77%
Dec 2023 2.40M -7.01M -291.52%
Mar 2024 2.73M -1.85M -67.81%
ThermoGenesis Holdings, Inc. (NASDAQ:THMO): Analyst Estimates
2027 25.11M 828.83K 3.3%
  • Analysts Price target

  • Financials & Ratios estimates

ThermoGenesis Holdings, Inc. (NASDAQ:THMO): Earnings per share (EPS)
2024-03-28 -0.01 -1.9387
2024-04-15 -0.01585 -2.33
ThermoGenesis Holdings, Inc. (NASDAQ:THMO): Debt to assets
Jun 2023 17608000 14.98M 85.08%
Sep 2023 15921000 12.65M 79.51%
Dec 2023 11232000 14.81M 131.91%
Mar 2024 10087000 11.17M 110.78%
ThermoGenesis Holdings, Inc. (NASDAQ:THMO): Cash Flow
Jun 2023 -812K -590K 0
Sep 2023 -251K -180K 0
Dec 2023 -2.04M -192K 217K
Mar 2024 -505K -20K -299K

ThermoGenesis Holdings alternative data

ThermoGenesis Holdings, Inc. (NASDAQ:THMO): Employee count
Aug 2023 40
Sep 2023 40
Oct 2023 40
Nov 2023 40
Dec 2023 40
Jan 2024 40
Feb 2024 40
Mar 2024 40
Apr 2024 40
May 2024 25
Jun 2024 25
Jul 2024 25

ThermoGenesis Holdings other data

17.19% +11.85%
of THMO is owned by hedge funds
63.71K +43.94K
shares is hold by hedge funds

ThermoGenesis Holdings, Inc. (NASDAQ:THMO): Insider trades (number of shares)
Period Buy Sel
Nov 2023 0 600000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
XU XIAOCHUN director, 10 percent owner, off..
Common Stock 600,000 $1.02 $612,000
Purchase
XU XIAOCHUN director, 10 percent owner, off..
Warrants to Purchase Common Stock 352,942 N/A N/A
Sale
XU XIAOCHUN director, 10 percent owner, off..
Common Stock 683,824 N/A N/A
Purchase
XU XIAOCHUN director, 10 percent owner, off..
Common Stock 1,367,648 N/A N/A
Purchase
XU XIAOCHUN director, 10 percent owner, off..
Common Stock 683,824 N/A N/A
Purchase
JOSEPH THOMIS director
Common Stock 35,000 N/A N/A
Purchase
BOYALIFE (HONG KONG) LTD 10 percent owner
Warrants to purchase common stock 2,941,177 N/A N/A
Purchase
BOYALIFE (HONG KONG) LTD 10 percent owner
Common Stock 6,102,942 N/A N/A
Sale
HARRIS KENNETH 10 percent owner, other: Former..
Common Stock 2,200 N/A N/A
Sale
HARRIS KENNETH 10 percent owner, other: Former..
Common Stock 48,468 N/A N/A
Insider Compensation
Dr. Xiaochun Xu M.B.A., Ph.D. (1971) Chairman & Chief Executive Officer
$781,000
Mr. Jeffery Cauble CPA (1973) Chief Financial Officer, Principal Financial & Accounting Officer and Corporation Sec.
$244,000
Wednesday, 12 June 2024
investorplace.com
Monday, 13 November 2023
Seeking Alpha
Wednesday, 8 November 2023
PRNewsWire
Tuesday, 8 August 2023
PRNewsWire
Monday, 15 May 2023
Seeking Alpha
Thursday, 16 March 2023
InvestorPlace
Wednesday, 15 March 2023
The Motley Fool
InvestorPlace
Saturday, 12 November 2022
Seeking Alpha
Thursday, 10 November 2022
Zacks Investment Research
Monday, 7 November 2022
PRNewsWire
Saturday, 13 August 2022
Seeking Alpha
Tuesday, 9 August 2022
PRNewsWire
Thursday, 28 July 2022
PennyStocks
Wednesday, 15 June 2022
PennyStocks
Thursday, 19 May 2022
Seeking Alpha
Monday, 28 March 2022
Seeking Alpha
Monday, 15 November 2021
Benzinga
Friday, 12 November 2021
Seeking Alpha
Friday, 5 November 2021
PRNewsWire
Tuesday, 14 September 2021
PRNewsWire
Tuesday, 31 August 2021
Zacks Investment Research
  • What's the price of ThermoGenesis Holdings stock today?

    One share of ThermoGenesis Holdings stock can currently be purchased for approximately $0.

  • When is ThermoGenesis Holdings's next earnings date?

    Unfortunately, ThermoGenesis Holdings's (THMO) next earnings date is currently unknown.

  • Does ThermoGenesis Holdings pay dividends?

    No, ThermoGenesis Holdings does not pay dividends.

  • How much money does ThermoGenesis Holdings make?

    ThermoGenesis Holdings has a market capitalization of 2.37M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 9.9% to 9.45M US dollars. ThermoGenesis Holdings made a loss 17.98M US dollars in net income (profit) last year or -$2.33 on an earnings per share basis.

  • What is ThermoGenesis Holdings's stock symbol?

    ThermoGenesis Holdings, Inc. is traded on the NASDAQ under the ticker symbol "THMO".

  • What is ThermoGenesis Holdings's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of ThermoGenesis Holdings?

    Shares of ThermoGenesis Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are ThermoGenesis Holdings's key executives?

    ThermoGenesis Holdings's management team includes the following people:

    • Dr. Xiaochun Xu M.B.A., Ph.D. Chairman & Chief Executive Officer(age: 54, pay: $781,000)
    • Mr. Jeffery Cauble CPA Chief Financial Officer, Principal Financial & Accounting Officer and Corporation Sec.(age: 52, pay: $244,000)
  • How many employees does ThermoGenesis Holdings have?

    As Jul 2024, ThermoGenesis Holdings employs 25 workers, which is 38% less then previous quarter.

  • When ThermoGenesis Holdings went public?

    ThermoGenesis Holdings, Inc. is publicly traded company for more then 38 years since IPO on 5 Jun 1987.

  • What is ThermoGenesis Holdings's official website?

    The official website for ThermoGenesis Holdings is thermogenesis.com.

  • Where are ThermoGenesis Holdings's headquarters?

    ThermoGenesis Holdings is headquartered at 2711 Citrus Road, Rancho Cordova, CA.

  • How can i contact ThermoGenesis Holdings?

    ThermoGenesis Holdings's mailing address is 2711 Citrus Road, Rancho Cordova, CA and company can be reached via phone at +91 68585100.

ThermoGenesis Holdings company profile:

ThermoGenesis Holdings, Inc.

thermogenesis.com
Exchange:

NASDAQ

Full time employees:

25

Industry:

Medical - Devices

Sector:

Healthcare

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

2711 Citrus Road
Rancho Cordova, CA 95742

CIK: 0000811212
ISIN: US88362L2097
CUSIP: 88362L100